BETA
Home MEPs Dossiers Committees Subjects Blog About Dumps
download json


2013/0207(NLE) Subjecting 5-(2-aminopropyl)indole to control measures

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead LIBE JIMÉNEZ-BECERRIL BARRIO Teresa (icon: PPE PPE)
Committee Opinion ENVI
Lead committee dossier:
Legal Basis:
Treaty on the European Union (after Amsterdam) M 039-p1

Events

2015/10/20
   Final act published in Official Journal
Details

PURPOSE: to subject 5-(2-aminopropyl)indole to control measures.

NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2015/1876 on subjecting 5-(2-aminopropyl)indole to control measures.

CONTENT: the Council adopted an implementing decision on subjecting the new psychoactive substance 5-(2-aminopropyl)indole to control measures.

The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects which has been detected in samples of a product sold as a ‘legal high’ called ‘Benzo Fury’, and in tablets resembling ecstasy.

The implementing Decision implements Decision 2005/387/JHA that confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union.

A risk assessment report on the new psychoactive substance 5-(2-aminopropyl)indole was drawn up in accordance with Decision 2005/387/JHA by the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The report revealed that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses.

However, as a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union.

As of the day of entry into force of this Decision, Decision 2013/496/EU ceases to produce effects, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5-(2-aminopropyl)indole to control measures and criminal penalties in their national laws.

The United Kingdom is not bound by Decision 2005/387/JHA and is therefore not taking part in the adoption of this Decision, which implements Decision 2005/387/JHA, and is not bound by it or subject to its application.

ENTRY INTO FORCE: 21.10.2015.

Documents
Decision 2015/1876
OJ L 275 20.10.2015, p. 0043
2015/10/08
   EP/CSL - Act adopted by Council after consultation of Parliament
2015/10/08
   EP - End of procedure in Parliament
2015/10/06
   EP - Results of vote in Parliament
Documents
Results of vote in Parliament
2015/10/06
   EP - Decision by Parliament
Details

The European Parliament adopted by 656 votes to 5, with 33 abstentions, a legislative resolution on the draft Council implementing decision on subjecting 5-(2-aminopropyl)indole to control measures.

In line with the Committee on Civil Liberties, Justice and Home Affairs, the European Parliament approved the Council draft aiming to subject 5-(2-aminopropyl)indole to control measures.

Documents
T8-0327/2015
2015/09/28
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Teresa JIMÉNEZ-BECERRIL BARRIO (EPP, ES) on the draft Council implementing decision on subjecting 5-(2-aminopropyl)indole to control measures.

The committee approved the Council draft which seeks to invite the Member States to subject 5-(2-aminopropyl)indole to control measures.

In compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substances. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2014.

Documents
A8-0263/2015
2015/09/22
   EP - Vote in committee
2015/09/03
   EP - JIMÉNEZ-BECERRIL BARRIO Teresa (PPE) appointed as rapporteur in LIBE
2015/09/01
   EP - Committee draft report
Documents
PE564.980
2015/07/09
   EP - Committee referral announced in Parliament
2015/07/03
   CSL - Legislative proposal
Details

PURPOSE: to subject 5-(2-aminopropyl)indole to control measures.

PROPOSED ACT: Implementing Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 5-(2-aminopropyl)indole. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2013.

The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects. 5-(2-aminopropyl)indole has been found mostly in powder form but also in tablet and capsule form. It is commercially available on the internet and from 'head shops', marketed as a 'research chemical'.

The existing information and data suggest that the acute toxicity of 5-(2-aminopropyl)indole can provoke adverse effects in humans.

There have been a total of 24 fatalities registered in four Member States from April to August 2012, in relation to which 5-(2-aminopropyl)indole alone, or in combination with other substances, was detected in post-mortem samples.

Nine European countries have reported to the EMCDDA and to the European Police Office (Europol) that they reported detection of 5-(2-aminopropyl)indole.

Six Member States already control 5-(2-aminopropyl)indole by means of different types of legislative provisions.

The Risk Assessment Reports reveal that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses.

However, the available evidence and information provides sufficient ground for subjecting 5-(2-aminopropyl)indole to control measures across the Union. As a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union.

CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 5-(2-aminopropyl)indole to control measures across the Union .

Decision 2013/496/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5(2-aminopropyl)indole to control measures and criminal penalties in their national laws.

The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.

Documents
10012/2015
2015/07/02
   EC - Legislative proposal published
Details

PURPOSE: to subject 5-(2-aminopropyl)indole to control measures.

PROPOSED ACT: Implementing Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 5-(2-aminopropyl)indole. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2013.

The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects. 5-(2-aminopropyl)indole has been found mostly in powder form but also in tablet and capsule form. It is commercially available on the internet and from 'head shops', marketed as a 'research chemical'.

The existing information and data suggest that the acute toxicity of 5-(2-aminopropyl)indole can provoke adverse effects in humans.

There have been a total of 24 fatalities registered in four Member States from April to August 2012, in relation to which 5-(2-aminopropyl)indole alone, or in combination with other substances, was detected in post-mortem samples.

Nine European countries have reported to the EMCDDA and to the European Police Office (Europol) that they reported detection of 5-(2-aminopropyl)indole.

Six Member States already control 5-(2-aminopropyl)indole by means of different types of legislative provisions.

The Risk Assessment Reports reveal that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses.

However, the available evidence and information provides sufficient ground for subjecting 5-(2-aminopropyl)indole to control measures across the Union. As a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union.

CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 5-(2-aminopropyl)indole to control measures across the Union .

Decision 2013/496/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5(2-aminopropyl)indole to control measures and criminal penalties in their national laws.

The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.

Documents
10012/2015

Documents

Activities

Votes

A8-0263/2015 - Teresa Jiménez-Becerril Barrio - Vote unique #

2015/10/06 Outcome: +: 656, 0: 33, -: 5
DE FR IT ES PL RO GB HU CZ BE SE EL PT AT NL BG FI SK HR DK LT IE LV SI CY MT EE LU
Total
90
72
68
49
47
30
59
20
21
19
19
19
18
18
25
16
12
12
11
11
10
10
8
8
6
6
5
4
icon: PPE PPE
204

Germany PPE

30

France PPE

19

Italy PPE

15

Spain PPE

14

Poland PPE

23

Romania PPE

13

Hungary PPE

11

Czechia PPE

7

Belgium PPE

3

Sweden PPE

4

Greece PPE

5

Portugal PPE

6

Austria PPE

5

Netherlands PPE

5

Bulgaria PPE

7

Finland PPE

3

Slovakia PPE

5

Croatia PPE

5

Denmark PPE

For (1)

Bendt BENDTSEN
1

Lithuania PPE

2

Ireland PPE

4

Latvia PPE

4

Slovenia PPE

5

Cyprus PPE

2

Malta PPE

3

Estonia PPE

For (1)

Tunne KELAM
1

Luxembourg PPE

2
icon: S&D S&D
180

Germany S&D

26

France S&D

13

Italy S&D

27

Spain S&D

13

Poland S&D

4

Romania S&D

14

United Kingdom S&D

21

Hungary S&D

4

Czechia S&D

4

Belgium S&D

4

Sweden S&D

5

Greece S&D

3

Portugal S&D

8

Austria S&D

5

Netherlands S&D

2

Bulgaria S&D

4

Finland S&D

2

Slovakia S&D

4

Croatia S&D

2

Denmark S&D

3

Lithuania S&D

2

Ireland S&D

For (1)

Nessa CHILDERS
1

Latvia S&D

1

Slovenia S&D

For (1)

Tanja FAJON
1

Cyprus S&D

2

Malta S&D

3

Estonia S&D

For (1)

Marju LAURISTIN
1

Luxembourg S&D

For (1)

Mady DELVAUX
1
icon: ALDE ALDE
65

Germany ALDE

4

France ALDE

7

Spain ALDE

8

Romania ALDE

2

United Kingdom ALDE

1

Czechia ALDE

4

Belgium ALDE

6

Sweden ALDE

3

Portugal ALDE

2

Austria ALDE

For (1)

Angelika MLINAR
1

Netherlands ALDE

7

Bulgaria ALDE

4

Finland ALDE

4

Croatia ALDE

2

Denmark ALDE

2

Lithuania ALDE

3

Ireland ALDE

For (1)

Marian HARKIN
1

Latvia ALDE

1

Slovenia ALDE

For (1)

Ivo VAJGL
1

Estonia ALDE

2
icon: Verts/ALE Verts/ALE
48

Germany Verts/ALE

12

France Verts/ALE

6

Spain Verts/ALE

4

United Kingdom Verts/ALE

5

Hungary Verts/ALE

2

Belgium Verts/ALE

2

Sweden Verts/ALE

4

Austria Verts/ALE

3

Netherlands Verts/ALE

2

Finland Verts/ALE

For (1)

Heidi HAUTALA
1

Croatia Verts/ALE

For (1)

Davor ŠKRLEC
1

Denmark Verts/ALE

For (1)

Margrete AUKEN
1

Lithuania Verts/ALE

For (1)

Bronis ROPĖ
1

Latvia Verts/ALE

1

Slovenia Verts/ALE

For (1)

Igor ŠOLTES
1

Estonia Verts/ALE

For (1)

Indrek TARAND
1

Luxembourg Verts/ALE

For (1)

Claude TURMES
1
icon: GUE/NGL GUE/NGL
48

Germany GUE/NGL

8

France GUE/NGL

4

Italy GUE/NGL

3

Spain GUE/NGL

10

United Kingdom GUE/NGL

1

Czechia GUE/NGL

3

Sweden GUE/NGL

For (1)

Malin BJÖRK
1

Greece GUE/NGL

5

Portugal GUE/NGL

2

Netherlands GUE/NGL

3

Finland GUE/NGL

For (1)

Merja KYLLÖNEN
1

Denmark GUE/NGL

For (1)

Rina Ronja KARI
1

Ireland GUE/NGL

Abstain (1)

Luke Ming FLANAGAN
4

Cyprus GUE/NGL

2
icon: ECR ECR
56

Germany ECR

8

Italy ECR

2

Poland ECR

18

United Kingdom ECR

9

Czechia ECR

2

Belgium ECR

3

Greece ECR

For (1)

Notis MARIAS
1

Netherlands ECR

2

Bulgaria ECR

1

Finland ECR

For (1)

Jussi HALLA-AHO
1

Slovakia ECR

3

Croatia ECR

For (1)

Ruža TOMAŠIĆ
1

Denmark ECR

3

Lithuania ECR

1

Latvia ECR

For (1)

Roberts ZĪLE
1
icon: ENF ENF
38

France ENF

21

Italy ENF

5

Poland ENF

For (1)

Michał MARUSIK
1

Romania ENF

1

United Kingdom ENF

Abstain (1)

Janice ATKINSON
1

Belgium ENF

For (1)

Gerolf ANNEMANS
1

Austria ENF

4

Netherlands ENF

4
icon: EFDD EFDD
42

France EFDD

1

Italy EFDD

16

Poland EFDD

1

United Kingdom EFDD

20

Czechia EFDD

Against (1)

Petr MACH
1

Sweden EFDD

2

Lithuania EFDD

For (1)

Rolandas PAKSAS
1
icon: NI NI
12

Germany NI

2

France NI

For (1)

Bruno GOLLNISCH
1

United Kingdom NI

For (1)

Diane DODDS
1

Hungary NI

3

Greece NI

5

History

(these mark the time of scraping, not the official date of the change)

2023-08-03Show (2) Changes | Timetravel
docs/0
date
2015-07-03T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10012%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 10012/2015
summary
type
Legislative proposal
body
CSL
events/0/date
Old
2015-07-03T00:00:00
New
2015-07-02T00:00:00
2021-12-18Show (8) Changes | Timetravel
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE564.980
New
https://www.europarl.europa.eu/doceo/document/LIBE-PR-564980_EN.html
events/1/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament
events/2/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee
events/3/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-8-2015-0263_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-8-2015-0263_EN.html
events/5
date
2015-10-06T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2015-0327_EN.html title: T8-0327/2015
summary
events/5
date
2015-10-06T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2015-0327_EN.html title: T8-0327/2015
summary
procedure/Modified legal basis
Rules of Procedure EP 159
procedure/Other legal basis
Rules of Procedure EP 159
2020-01-19Show (4) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: JIMÉNEZ-BECERRIL BARRIO Teresa date: 2015-09-03T00:00:00 group: European People's Party (Christian Democrats) abbr: PPE
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2015-09-03T00:00:00
rapporteur
name: JIMÉNEZ-BECERRIL BARRIO Teresa group: European People's Party (Christian Democrats) abbr: PPE
events/3/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0263&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-8-2015-0263_EN.html
events/5/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0327
New
http://www.europarl.europa.eu/doceo/document/TA-8-2015-0327_EN.html
2019-07-06Show (17) Changes | Timetravel
activities
  • date: 2015-07-03T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10012%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 10012/2015 body: EC commission: DG: url: http://ec.europa.eu/justice/ title: Justice Commissioner: JOUROVÁ Věra type: Legislative proposal published
  • date: 2015-07-09T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa
  • date: 2015-09-22T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0263&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0263/2015 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa date: 2015-09-28T00:00:00
  • date: 2015-10-06T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=26164&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0327 type: Decision by Parliament, 1st reading/single reading title: T8-0327/2015 body: EP type: Results of vote in Parliament
  • date: 2015-10-08T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament
  • date: 2015-10-20T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1876 title: Decision 2015/1876 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2015:275:TOC title: OJ L 275 20.10.2015, p. 0043 type: Final act published in Official Journal
commission
  • body: EC dg: Justice and Consumers commissioner: JOUROVÁ Věra
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2015-09-03T00:00:00
rapporteur
name: JIMÉNEZ-BECERRIL BARRIO Teresa group: European People's Party (Christian Democrats) abbr: PPE
committees/0
body
EP
responsible
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
opinion
False
committees/1
body
EP
responsible
True
committee
LIBE
date
2015-09-03T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa
docs
  • date: 2015-09-01T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE564.980 title: PE564.980 type: Committee draft report body: EP
events
  • date: 2015-07-03T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10012%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 10012/2015 summary: PURPOSE: to subject 5-(2-aminopropyl)indole to control measures. PROPOSED ACT: Implementing Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 5-(2-aminopropyl)indole. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2013. The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects. 5-(2-aminopropyl)indole has been found mostly in powder form but also in tablet and capsule form. It is commercially available on the internet and from 'head shops', marketed as a 'research chemical'. The existing information and data suggest that the acute toxicity of 5-(2-aminopropyl)indole can provoke adverse effects in humans. There have been a total of 24 fatalities registered in four Member States from April to August 2012, in relation to which 5-(2-aminopropyl)indole alone, or in combination with other substances, was detected in post-mortem samples. Nine European countries have reported to the EMCDDA and to the European Police Office (Europol) that they reported detection of 5-(2-aminopropyl)indole. Six Member States already control 5-(2-aminopropyl)indole by means of different types of legislative provisions. The Risk Assessment Reports reveal that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses. However, the available evidence and information provides sufficient ground for subjecting 5-(2-aminopropyl)indole to control measures across the Union. As a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union. CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 5-(2-aminopropyl)indole to control measures across the Union . Decision 2013/496/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5(2-aminopropyl)indole to control measures and criminal penalties in their national laws. The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.
  • date: 2015-07-09T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2015-09-22T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2015-09-28T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0263&language=EN title: A8-0263/2015 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Teresa JIMÉNEZ-BECERRIL BARRIO (EPP, ES) on the draft Council implementing decision on subjecting 5-(2-aminopropyl)indole to control measures. The committee approved the Council draft which seeks to invite the Member States to subject 5-(2-aminopropyl)indole to control measures. In compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substances. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2014.
  • date: 2015-10-06T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=26164&l=en title: Results of vote in Parliament
  • date: 2015-10-06T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0327 title: T8-0327/2015 summary: The European Parliament adopted by 656 votes to 5, with 33 abstentions, a legislative resolution on the draft Council implementing decision on subjecting 5-(2-aminopropyl)indole to control measures. In line with the Committee on Civil Liberties, Justice and Home Affairs, the European Parliament approved the Council draft aiming to subject 5-(2-aminopropyl)indole to control measures.
  • date: 2015-10-08T00:00:00 type: Act adopted by Council after consultation of Parliament body: EP/CSL
  • date: 2015-10-08T00:00:00 type: End of procedure in Parliament body: EP
  • date: 2015-10-20T00:00:00 type: Final act published in Official Journal summary: PURPOSE: to subject 5-(2-aminopropyl)indole to control measures. NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2015/1876 on subjecting 5-(2-aminopropyl)indole to control measures. CONTENT: the Council adopted an implementing decision on subjecting the new psychoactive substance 5-(2-aminopropyl)indole to control measures. The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects which has been detected in samples of a product sold as a ‘legal high’ called ‘Benzo Fury’, and in tablets resembling ecstasy. The implementing Decision implements Decision 2005/387/JHA that confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union. A risk assessment report on the new psychoactive substance 5-(2-aminopropyl)indole was drawn up in accordance with Decision 2005/387/JHA by the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The report revealed that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses. However, as a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union. As of the day of entry into force of this Decision, Decision 2013/496/EU ceases to produce effects, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5-(2-aminopropyl)indole to control measures and criminal penalties in their national laws. The United Kingdom is not bound by Decision 2005/387/JHA and is therefore not taking part in the adoption of this Decision, which implements Decision 2005/387/JHA, and is not bound by it or subject to its application. ENTRY INTO FORCE: 21.10.2015. docs: title: Decision 2015/1876 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1876 title: OJ L 275 20.10.2015, p. 0043 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2015:275:TOC
links
other
  • body: EC dg: url: http://ec.europa.eu/justice/ title: Justice commissioner: JOUROVÁ Věra
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/03855
New
  • LIBE/8/03855
procedure/final/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1876
New
https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1876
procedure/instrument
Old
Decision
New
  • Decision
  • See also Decision 2005/387/JHA 2003/0215(CNS)
procedure/subject
Old
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
7.30.30.04
Action to combat drugs and drug-trafficking
procedure/summary
  • See also Decision 2005/387/JHA
procedure/title
Old
Implementing decision on subjecting 5-(2-aminopropyl)indole to control measures
New
Subjecting 5-(2-aminopropyl)indole to control measures
2016-07-06Show (4) Changes | Timetravel
activities/5
date
2015-10-08T00:00:00
body
EP/CSL
type
Act adopted by Council after consultation of Parliament
activities/6
date
2015-10-20T00:00:00
docs
type
Final act published in Official Journal
procedure/final
url
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1876
title
Decision 2015/1876
procedure/stage_reached
Old
Awaiting final decision
New
Procedure completed
2016-02-11Show (2) Changes | Timetravel
activities/4/docs/0
url
http://www.europarl.europa.eu/oeil/popups/sda.do?id=26164&l=en
type
Results of vote in Parliament
title
Results of vote in Parliament
activities/4/type
Old
Decision by Parliament, 1st reading/single reading
New
Results of vote in Parliament
2015-10-21Show (11) Changes | Timetravel
activities/0/commission/0
DG
Commissioner
JOUROVÁ Věra
activities/1/committees/1/date
2015-09-03T00:00:00
activities/1/committees/1/rapporteur
  • group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa
activities/2
date
2015-09-22T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/3
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0263&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0263/2015
type
Committee report tabled for plenary, 1st reading/single reading
committees
date
2015-09-28T00:00:00
activities/4
date
2015-10-06T00:00:00
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0327 type: Decision by Parliament, 1st reading/single reading title: T8-0327/2015
body
EP
type
Decision by Parliament, 1st reading/single reading
committees/1/date
2015-09-03T00:00:00
committees/1/rapporteur
  • group: EPP name: JIMÉNEZ-BECERRIL BARRIO Teresa
other/0
body
EC
dg
commissioner
JOUROVÁ Věra
procedure/Modified legal basis
Rules of Procedure of the European Parliament EP 150
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting final decision
2015-07-31Show (1) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject 5-(2-aminopropyl)indole to control measures.

    PROPOSED ACT: Implementing Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 5-(2-aminopropyl)indole. The risk assessment report was subsequently submitted to the Commission and to the Council on 16 April 2013.

    The substance 5-(2-aminopropyl)indole is a synthetic derivative of indole substituted at the phenyl side of the indole ring system. It appears to be a stimulant substance that may also have hallucinogenic effects. 5-(2-aminopropyl)indole has been found mostly in powder form but also in tablet and capsule form. It is commercially available on the internet and from 'head shops', marketed as a 'research chemical'.

    The existing information and data suggest that the acute toxicity of 5-(2-aminopropyl)indole can provoke adverse effects in humans.

    There have been a total of 24 fatalities registered in four Member States from April to August 2012, in relation to which 5-(2-aminopropyl)indole alone, or in combination with other substances, was detected in post-mortem samples.

    Nine European countries have reported to the EMCDDA and to the European Police Office (Europol) that they reported detection of 5-(2-aminopropyl)indole.

    Six Member States already control 5-(2-aminopropyl)indole by means of different types of legislative provisions.

    The Risk Assessment Reports reveal that there is limited scientific evidence available on 5-(2-aminopropyl)indole and pointed out that further research would be needed to determine the health and social risks that it poses.

    However, the available evidence and information provides sufficient ground for subjecting 5-(2-aminopropyl)indole to control measures across the Union. As a result of the health risks that it poses, as documented by its detection in several reported fatalities, of the fact that users may unknowingly consume it, and of the lack of medical value or use, 5-(2-aminopropyl)indole should be subjected to control measures across the Union.

    CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 5-(2-aminopropyl)indole to control measures across the Union.

    Decision 2013/496/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 5(2-aminopropyl)indole to control measures and criminal penalties in their national laws.

    The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.
2015-07-15Show (5) Changes
activities
  • date: 2015-07-03T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10012%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 10012/2015 type: Legislative proposal published body: EC commission:
  • date: 2015-07-09T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
committees
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
    procedure
    dossier_of_the_committee
    LIBE/8/03855
    reference
    2013/0207(NLE)
    subtype
    Consultation of Parliament
    legal_basis
    Treaty on the European Union (after Amsterdam) M 039-p1
    stage_reached
    Awaiting committee decision
    summary
    See also Decision 2005/387/JHA
    instrument
    Decision
    title
    Implementing decision on subjecting 5-(2-aminopropyl)indole to control measures
    type
    NLE - Non-legislative enactments
    subject
    7.30.30.04 Action to combat drugs and drug-trafficking
    @parltrack
    @parltrack@eupolicy.social
    [javascript protected email address]
    code AGPLv3.0+
    data ODBLv1.0
    site content CC-By-Sa-3.0

    ParlTrack - 2011-2024

    © European Union, 2011 – Source: European Parliament
    Hosted by AS250.net Foundation